But have pharma and payers learned enough from earlier pilots to make modern risk-sharing deals work?
The Kim Kardashian debacle aside, what makes the platform so potentially valuable to pharma and healthcare marketers is its visual story-telling capability.
MM&M last year named its inaugural class of 16 Femmes and 20 Women to Watch. Who should be considered for this year's list of breakthough women?
Here's everything you missed or may want to revisit from MM&M's inaugural Hall of Femme event in June.